High-mobility Group Box 1 is Associated with Neurological Outcome in Patients with Post-cardiac Arrest Syndrome After Out-of-hospital Cardiac Arrest
Overview
Affiliations
Background: Alarmins, including high-mobility group box 1 (HMGB-1), can be released from damaged tissues and activated cells as inflammatory mediators. We aimed to evaluate HMGB-1 and mitochondrial DNA dynamics and estimate the prognostic value for neurological outcome in patients with post-cardiac arrest syndrome after out-of-hospital cardiac arrest.
Methods: We evaluated the dynamics of HMGB-1, mitochondrial DNA, and other variables in patients with return of spontaneous circulation after out-of-hospital cardiac arrest. Patients were divided into two groups according to the cerebral performance category at 30 days: the favourable outcome group (cerebral performance categories 1 and 2) and unfavourable group (≥3).
Results: Twenty-one patients were included, and 11 demonstrated favourable outcomes. HMGB-1 levels and mitochondrial DNA on day 1 were significantly higher than on days 2, 3, 5, and 7. Plasma levels of HMGB-1 on day 1 correlated with prognostic parameters (estimated interval to return of spontaneous circulation, lactate, and NH3), tissue damage, systemic inflammation, and disease severity. HMGB-1 on day 1 in the unfavourable group was significantly higher than in the favourable group (median [interquartile range] 15.5 [6.65-18.7], 39.4 [17-69.5], P = 0.009). These findings were not observed regarding mitochondrial DNA. Regarding HMGB-1 prediction accuracy for a good neurological outcome, the area under the receiver operating characteristic curve was 0.864 (95 % confidence interval 0.702, 1.000).
Conclusions: HMGB-1 may be involved in acute-phase post-cardiac arrest syndrome pathophysiology, and an increase in plasma levels may be associated with a poor neurological outcome. The study was registered with the University Hospital Medical Information Network Clinical Trials Registry ID: UMIN000006714.
Mao J, Li D, Zhang H, Wang X, Liu D BMC Pulm Med. 2021; 21(1):66.
PMID: 33632166 PMC: 7905766. DOI: 10.1186/s12890-021-01437-2.
Ultrafast Hypothermia Selectively Mitigates the Early Humoral Response After Cardiac Arrest.
Boissady E, Kohlhauer M, Lidouren F, Hocini H, Lefebvre C, Chateau-Jouber S J Am Heart Assoc. 2020; 9(23):e017413.
PMID: 33198571 PMC: 7763769. DOI: 10.1161/JAHA.120.017413.
Harrington J, Huh J, Schenck E, Nakahira K, Siempos I, Choi A Chest. 2019; 156(6):1120-1136.
PMID: 31381882 PMC: 6904860. DOI: 10.1016/j.chest.2019.07.014.
Mitochondrial Damage-Associated Molecular Patterns: From Inflammatory Signaling to Human Diseases.
Grazioli S, Pugin J Front Immunol. 2018; 9:832.
PMID: 29780380 PMC: 5946030. DOI: 10.3389/fimmu.2018.00832.
The Role of Danger Signals in the Pathogenesis and Perpetuation of Critical Illness.
Ma K, Schenck E, Pabon M, Choi A Am J Respir Crit Care Med. 2017; 197(3):300-309.
PMID: 28977759 PMC: 5811949. DOI: 10.1164/rccm.201612-2460PP.